Singapore markets closed
Straits Times Index
3,332.80 -10.55 (-0.32%) Nikkei
39,583.08 +241.54 (+0.61%) Hang Seng
17,718.61 +2.14 (+0.01%) FTSE 100
8,164.12 -15.56 (-0.19%) Bitcoin USD
61,097.62 -538.95 (-0.87%) CMC Crypto 200
1,268.09 -15.74 (-1.23%)
Lonza Group AG (LONN.SW)
Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
At close: 05:30PM CEST
| Previous close | 486.80 |
| Open | 488.20 |
| Bid | 490.40 x 0 |
| Ask | 490.50 x 0 |
| Day's range | 486.90 - 493.40 |
| 52-week range | 308.60 - 559.40 |
| Volume | |
| Avg. volume | 189,866 |
| Market cap | 35.366B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | 55.23 |
| EPS (TTM) | 8.88 |
| Earnings date | 25 Jul 2024 |
| Forward dividend & yield | 4.00 (0.82%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | 715.25 |
- GuruFocus.com
Acumen Pharmaceuticals Inc (ABOS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Explore key insights from Acumen Pharmaceuticals' Q1 2024 earnings, focusing on their innovative Alzheimer's treatments and financial outlook.
- GuruFocus.com
Maravai LifeSciences Holdings Inc (MRVI) (Q1 2024) Earnings Call Transcript Highlights: ...
Despite a net loss, MRVI showcases strategic expansions and robust partnerships, setting the stage for future growth.
PR NewswireNeuroSense Announces First Quarter 2024 Business Update
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
© 2024 Yahoo. All rights reserved.